Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (353)

1

Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer

enthalten in: Cancer medicine | 2024

von Uekusa, R. | Yokoi, A. | Watanabe, E. | +9

2

Successful Management of Ovarian Cancer Progressing on Olaparib by Niraparib Following Cytoreduction : A Case Report

enthalten in: In vivo (Athens, Greece) | 2024

von Endo, Y. | Kamo, N. | Kato, A. | +5

3

NRG-GY012 : Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer

enthalten in: Cancer | 2024

von Rimel, B. | Enserro, D. | Bender, D. | +10

4

The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer

enthalten in: International journal of technology assessment in health care | 2024

von Teppala, S. | Scuffham, P. | Tuffaha, H.

5

Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer

enthalten in: Gynecologic oncology | 2024

von Kim, J. | Kim, S. | Park, E. | +5

6

Promising Response of Olaparib in Patient With Germline ATM-Mutated Metastatic Gastric Cancer

enthalten in: Journal of investigative medicine high impact case reports | 2024

von Chan, K. | Rutazanaa, D. | Wray, C. | +3

7

Development of a simple high-performance liquid chromatography-ultraviolet detection method for olaparib in patients with ovarian cancer

enthalten in: Drug discoveries & therapeutics | 2024

von Yasu, T. | Nishijima, R. | Ikuta, R. | +2

8

Efficacy and safety of PARP inhibitors combined with antiangiogenic agents in the maintenance treatment of ovarian cancer : a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

enthalten in: Frontiers in pharmacology | 2024

von Wei, Y. | He, L. | Liu, T. | +6

9

Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions

enthalten in: Journal of Cancer | 2024

von Dong, M. | Luo, H. | Liu, R. | +8

10

Efficacy and safety of PARP inhibitors combined with antiangiogenic agents in the maintenance treatment of ovarian cancer: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

in: Frontiers in Pharmacology | 2024

von Yan Wei | Li He | Tao Liu | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]